Patents by Inventor Andrew Wu

Andrew Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911263
    Abstract: Systems, methods, and apparatuses for storing and/or shipping an intraocular lens (IOL) cartridge are provided. A system comprises a packaging comprising a passage. The IOL cartridge is removably disposed within the passage. The IOL cartridge comprises a nozzle and a compartment configured to receive an IOL. The nozzle is in fluid communication with the compartment. The IOL cartridge further comprises a dial configured to rotate upon withdrawal of the IOL cartridge from the passage, wherein an inner surface of the dial is exposed to the compartment. The dial is configured to fold the IOL and release the IOL cartridge from the packaging upon rotation of the dial.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: February 27, 2024
    Assignee: Alcon Inc.
    Inventors: Sudarshan B. Singh, Todd Taber, Yinghui Wu, Douglas Brent Wensrich, Trevor Haney, Andrew Check, Justin Benaquisto, Joe Marietta, Jonathan Penrod, Tim LaRoy, Bryce Porter
  • Publication number: 20240041512
    Abstract: Methods and system are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. In some embodiments, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy.
    Type: Application
    Filed: October 5, 2023
    Publication date: February 8, 2024
    Inventors: Andrew Wu, Benjamin Clark, Erik Thai, Nicolas Zadno, Denise Zarins
  • Publication number: 20230414160
    Abstract: Techniques for evaluating neural electrical activity of renal nerves of a patient for which a renal denervation procedure has been or is going to be performed are described. A distal portion of a guide catheter is inserted through an abdominal aorta so the distal portion is positioned adjacent to a renal artery ostium, or in a proximal portion of the renal artery. The guide catheter is used to insert a distal portion of a mapping catheter within the renal artery, and a stimulation electrode positioned in the abdominal aorta (within a specified distance of the renal artery ostium) is used to deliver electrical stimulation pulse(s) to evoke a neural electrical response from renal nerves in tissue surrounding the renal artery. A sense electrode positioned in the renal artery, downstream from the stimulation electrode, is used to sense the neural electrical activity evoked in response to the stimulation pulse(s).
    Type: Application
    Filed: June 23, 2023
    Publication date: December 28, 2023
    Inventors: Liang Zhai, Andrew WU, Neil Barman
  • Publication number: 20230404662
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 21, 2023
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Patent number: 11844569
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue are disclosed herein. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: August 15, 2023
    Date of Patent: December 19, 2023
    Assignee: Axon Therapies, Inc.
    Inventors: Dorin Panescu, Andrew Wu, Zoar Jacob Engelman, Mark Gelfand, Mark S. Leung
  • Publication number: 20230380901
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue are disclosed herein. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: August 15, 2023
    Publication date: November 30, 2023
    Inventors: Dorin PANESCU, Andrew WU, Zoar Jacob ENGELMAN, Mark GELFAND, Mark S. LEUNG
  • Publication number: 20230380896
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue are disclosed herein. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: August 7, 2023
    Publication date: November 30, 2023
    Inventors: Dorin PANESCU, Andrew WU, Zoar Jacob ENGELMAN, Mark GELFAND, Mark S. LEUNG
  • Patent number: 11801085
    Abstract: Methods and system are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues. In some embodiments, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: October 31, 2023
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Andrew Wu, Benjamin J. Clark, Erik Thai, Nicolas Zadno, Denise Zarins
  • Publication number: 20230310053
    Abstract: Described herein are systems and methods for performing a denervation procedure and determining an efficacy thereof. Such a system can include an excitation source, a controller, and a catheter with element(s) for delivering first ablation therapy from a first longitudinal location along a biological lumen and delivering second ablation therapy from a second longitudinal location longitudinally spaced apart from the first longitudinal location. A sensing subsystem of the system senses neural activity from a third longitudinal location along the biological lumen, to determine the efficacy of at least one of the first or second ablation therapies.
    Type: Application
    Filed: March 14, 2023
    Publication date: October 5, 2023
    Inventors: Andrew Wu, Neil Barman
  • Publication number: 20230306372
    Abstract: In an example embodiment, a deep neural network is used to predict a classification for ingested job listings for a piece of information that is missing from the ingested job listings. More particularly, the deep neural network may comprise a multi-layer perceptron with a plurality of rectifier linear units (ReLUs). For a given category of information, a plurality of different information entities may be evaluated by the multi-layer perceptron against features of a job listing, producing a probability prediction of reach of those information entities for the job listing. The information entity with the highest predicted probability is identified by the multi-layer perceptron as the predicted information entity for that given category of information for the job listing.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 28, 2023
    Inventors: Xilun Chen, Chen-Kun Chuang, Xing Wu, Fei Chen, Wenxuan Gao, Jingwei Wu, Rohan Rajiv, Swathi Singh, Mathias Arkayin, Andrew Wu
  • Publication number: 20230293229
    Abstract: Tissue treatment systems and methods are disclosed. A tissue treatment system comprises a signal generator, a sensing circuit coupleable to electrode(s) of a catheter, and a controller. The sensing circuit senses neural activity of nerves within tissue surrounding a biological lumen using electrode(s) of the catheter inserted into the biological lumen. The controller determines one or more characteristics of the sensed neural activity of the nerves within the tissue surrounding the biological lumen. The controller also selects one or more denervation parameters based on the one or more characteristics of the sensed neural activity, and controls the signal generator to generate, using the selected one or more denervation parameters, signals for performing a denervation procedure intended to denervate at least some of the nerves for which the neural activity was sensed.
    Type: Application
    Filed: March 13, 2023
    Publication date: September 21, 2023
    Inventors: Neil BARMAN, Andrew WU, Liang ZHAI, John W. OSBORN, Eric A. Schepis
  • Patent number: 11751939
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue are disclosed herein. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: September 12, 2023
    Assignee: Axon Therapies, Inc.
    Inventors: Dorin Panescu, Andrew Wu, Zoar Jacob Engelman, Mark Gelfand, Mark S. Leung
  • Publication number: 20230277240
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: April 21, 2023
    Publication date: September 7, 2023
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Patent number: 11712296
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: August 1, 2023
    Assignee: Axon Therapies, Inc.
    Inventors: Dorin Panescu, Andrew Wu, Zoar Jacob Engelman, Mark Gelfand, Mark S. Leung, Howard Levin
  • Patent number: 11666380
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 6, 2023
    Assignee: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Patent number: 11657829
    Abstract: A communication system with a noise cancellation (NC) assembly providing adaptive or dynamic noise cancellation. The NC assembly includes a localizer module determining, during a communication session (active speaking or during idle times), a location of the active talker. The NC assembly includes a beam generator forming a beam in the determined direction of the active talker to enhance the active talker speech. Once the NC assembly has determined the position of the active talker, the NC assembly assigns a microphone of the microphone array or generated beam in that active direction to be the “active signal” source. The NC assembly assigns a second microphone or beam to be the noise source for NC purposes, and this source may be selected to be in acoustic shadow of the first microphone used as the active signal source or may be the farthest away in its position from the active talker's position.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: May 23, 2023
    Assignee: Mitel Networks Corporation
    Inventors: Mirjana Popovic, Dieter Schulz, Roger Bastin, Andrew Wu, Logendra Naidoo
  • Publication number: 20220351742
    Abstract: A communication system with a noise cancellation (NC) assembly providing adaptive or dynamic noise cancellation. The NC assembly includes a localizer module determining, during a communication session (active speaking or during idle times), a location of the active talker. The NC assembly includes a beam generator forming a beam in the determined direction of the active talker to enhance the active talker speech. Once the NC assembly has determined the position of the active talker, the NC assembly assigns a microphone of the microphone array or generated beam in that active direction to be the “active signal” source. The NC assembly assigns a second microphone or beam to be the noise source for NC purposes, and this source may be selected to be in acoustic shadow of the first microphone used as the active signal source or may be the farthest away in its position from the active talker's position.
    Type: Application
    Filed: April 28, 2021
    Publication date: November 3, 2022
    Applicant: Mitel Networks Corporation
    Inventors: Mirjana Popovic, Dieter Schulz, Roger Bastin, Andrew Wu, Logendra Naidoo
  • Publication number: 20220079666
    Abstract: Catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a multi-electrode array configured to be delivered to a renal blood vessel. The array is selectively transformable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded, generally helical shape). The multi-electrode array is sized and shaped so that the electrodes or energy delivery elements contact an interior wall of the renal blood vessel when the array is in the deployed (e.g., helical) state. The electrodes or energy delivery elements are configured for direct and/or indirect application of thermal and/or electrical energy to heat or otherwise electrically modulate neural fibers that contribute to renal function or of vascular structures that feed or perfuse the neural fibers.
    Type: Application
    Filed: September 10, 2021
    Publication date: March 17, 2022
    Inventors: Vincent Ku, Robert Beetel, Andrew Wu, Denise Zarins, Maria Aboytes
  • Patent number: 11213674
    Abstract: Catheter assemblies for neuromodulation proximate a renal artery bifurcation and associated systems and methods are disclosed herein. A catheter assembly configured in accordance with a particular embodiment of the present technology can include a shaft having a proximal portion, a distal portion, and two therapeutic arms extending from the distal portion. The shaft can be configured to deliver the distal portion to a treatment site proximate a branch point or bifurcation in a renal blood vessel. The therapeutic arms can include energy delivery elements that are configured to deliver the therapeutically-effective energy to renal nerves proximate the branch point.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: January 4, 2022
    Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
    Inventors: Neil C. Barman, Robert J. Beetel, Benjamin J. Clark, Andrew Wu, Maria G. Aboytes, Denise Zarins
  • Publication number: 20210315625
    Abstract: Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may also be useful in the treatment of infertility associated with PCOS.
    Type: Application
    Filed: June 24, 2021
    Publication date: October 14, 2021
    Applicant: AblaCare, Inc.
    Inventors: Denise Marie ZARINS, Neil Chand BARMAN, Garrett Marc SCHWAB, Andrew WU